Share on StockTwits
 

Core Labs (NYSE:CLB) issued an update on its FY14 earnings guidance on Wednesday morning. The company provided EPS guidance of $6.00-6.25 for the period, compared to the Thomson Reuters consensus EPS estimate of $6.23, AmericanBankingNews.com reports. The company issued revenue guidance of $1.16-1.181 billion, compared to the consensus revenue estimate of $1.19 billion.Core Labs also updated its Q1 guidance to $1.43-1.45 EPS.

Shares of Core Labs (NYSE:CLB) traded down 0.45% on Wednesday, hitting $185.99. 501,346 shares of the company’s stock traded hands. Core Labs has a 52-week low of $116.88 and a 52-week high of $200.00. The stock has a 50-day moving average of $188.7 and a 200-day moving average of $173.9. The company has a market cap of $8.437 billion and a P/E ratio of 37.23.

Core Labs (NYSE:CLB) last released its earnings data on Thursday, January 30th. The company reported $1.43 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.40 by $0.03. The company had revenue of $276.30 million for the quarter, compared to the consensus estimate of $278.55 million. During the same quarter last year, the company posted $1.17 earnings per share. Core Labs’s revenue was up 8.6% compared to the same quarter last year. On average, analysts predict that Core Labs will post $5.30 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which is scheduled for Friday, February 21st. Investors of record on Friday, January 24th will be paid a dividend of 0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 1.08%. The ex-dividend date is Wednesday, January 22nd.

A number of analysts have recently weighed in on CLB shares. Analysts at Guggenheim downgraded shares of Core Labs from a buy rating to a neutral rating in a research note to investors on Monday, January 6th. On a related note, analysts at Barclays cut their price target on shares of Core Labs from $200.00 to $198.00 in a research note to investors on Tuesday, December 17th. Finally, analysts at Zacks reiterated a neutral rating on shares of Core Labs in a research note to investors on Thursday, December 5th. They now have a $198.00 price target on the stock. Ten research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Core Labs currently has an average rating of Hold and an average price target of $173.30.

Core Laboratories N.V. (NYSE:CLB) is a provider of reservoir description, production enhancement and reservoir management services to the oil and gas industry.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.